Translational Science in Drug Development: Surrogate Endpoints, Biomarkers, and More

As the biological mechanisms of diseases and pharmacological activities of therapeutics are better understood, this information provides opportunities to improve clinical trial efficiency. One such opportunity includes identification and use of surrogate endpoints that indicate disease progression...

As the biological mechanisms of diseases and pharmacological activities of therapeutics are better...

Read More